Investigating how the surrounding protein structure affects insulin production in type 1 diabetes.

The role of the peri-islet extracellular matrix in islet function and the pathogenesis of type 1 diabetes

NIH-funded research Colorado School of Mines · NIH-10896213

This study is looking at how the support structure around insulin-producing cells in the pancreas changes during type 1 diabetes and how these changes affect the cells' ability to survive and work properly, with the hope of finding new ways to help improve insulin production and overall function for people with this condition.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionColorado School of Mines NIH-funded
Lab location1 site (Golden, United States)
Project IDNIH-10896213 on NIH RePORTER

What this research studies

This research focuses on understanding the role of the extracellular matrix (ECM) surrounding pancreatic islets in type 1 diabetes (T1D). It examines how changes in this protein scaffold, particularly during immune cell infiltration, impact the survival and function of insulin-producing beta cells. The study employs innovative materials to mimic the ECM and investigates the interactions between beta cells and immune cells to uncover mechanisms that may lead to improved insulin secretion and islet function. By exploring these cellular interactions, the research aims to provide insights into the pathogenesis of T1D.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with type 1 diabetes who are experiencing challenges with insulin regulation.

Not a fit: Patients with type 2 diabetes or other forms of diabetes unrelated to autoimmune mechanisms may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance insulin production and preserve beta cell function in patients with type 1 diabetes.

How similar studies have performed: While some studies have explored the role of the ECM in diabetes, this research takes a novel approach by focusing specifically on the interactions between beta cells and immune cells in the context of T1D.

Where this research is happening

Golden, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.